// App-Quantinova.ai

: TMOD-02. DIFFUSE GLIOMATOSIS IN MOUSE MODEL OF GFAP TISSUE SPECIFIC KNOCK IN OF EGFRvIII AND KNOCK OUT OF p19 ARF

Researchers

Presenter

  • Gelareh Zadeh

Principal Investigators

  • N/A

Medical Centers

  • Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cyclin Dependent Kinase Inhibitor 2A

  • Glial fibrillary acidic protein

  • S100 calcium-binding protein B

Drug/Treatment

  • EGFRvIII

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A